Managing skeletal muscle dysfunction in COPD

European Respiratory Monograph

Volumn 59, Issue , 2013, Pages 164-173

  Troosters, Thierry ^a,b   Janssens, Wim ^a   Decramer, Marc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

COPD; Exercise; Physical activity; Rehabilitation; Skeletal muscle

Indexed keywords

ANTIOXIDANT; CORTICOSTEROID; GROWTH HORMONE; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN; TESTOSTERONE; VITAMIN D;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; DISEASE EXACERBATION; ENDURANCE TRAINING; EXERCISE; HEALTH PROGRAM; HUMAN; HYPOGONADISM; MAGNETIC STIMULATION; MORBIDITY; MORTALITY; MUSCLE ATROPHY; MUSCLE EXCITATION; MUSCLE FUNCTION; MUSCLE WEAKNESS; MYOPATHY; NEUROMUSCULAR ELECTRICAL STIMULATION; NONHUMAN; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RESISTANCE TRAINING; WHOLE BODY VIBRATION;

EID: 84874878101     PISSN: 1025448X     EISSN: 20756674     Source Type: Book Series    
DOI: 10.1183/1025448x.10012212     Document Type: Article

References (63)

1. van Wetering CR, van Nooten FE, Mol SJ, et al. Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial. Int J Chron Obstruct Pulmon Dis 2008; 3: 443-451.
2. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012; 40: 1115-1122.
3. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972-977.
4. Wust RC, Morse CI, de Haan, et al. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol 2008; 104: 103-110.
5. Hopkinson NS, Tennant RC, Dayer MJ, et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007; 8: 25.
6. Robles PG, Mathur S, Janaudis-Fereira T, et al. Measurement of peripheral muscle strength in individuals with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil Prev 2011; 31: 11-24.
7. Burtin C, Saey D, Saglam M, et al. Effectiveness of exercise training in patients with COPD: the role of muscle fatigue. Eur Respir J 2012; 40: 338-344.
8. Malaguti C, Napolis LM, Villaca D, et al. Relationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional status. J Strength Cond Res 2011; 25: 1795-1803.
9. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43: 1334-1359.
10. Troosters T, Casaburi R, Gosselink R, et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 19-38.
11. Mador MJ, Kufel TJ, Pineda LA, et al. Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. Am J Respir Crit Care Med 2001; 163: 930-935.
12. Vogiatzis I, Stratakos G, Simoes DC, et al. Effects of rehabilitative exercise on peripheral muscle TNF-a, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 2007; 62: 950-956.
13. Vogiatzis I, Terzis G, Stratakos G, et al. Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest 2011; 140: 744-752.
14. Brønstad E, Rognmo O, Erik TA, et al. High-intensity knee extensor training restores skeletal muscle function in COPD patients. Eur Respir J 2012; 40: 1130-1136.
15. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
16. Rabinovich RA, Mayer AM, Ardite E, et al. Skeletal muscle redox capacity is reduced in COPD patients with low BMI. Am J Respir Crit Care Med 2003; 167: A73.
17. Rabinovich RA, Ardite E, Mayer AM, et al. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 2006; 73: 757-761.
18. Gouzi F, Prefaut C, Abdellaoui A, et al. Blunted muscle angiogenic training-response in COPD patients versus sedentary controls. Eur Respir J 2012 [Epub ahead of print DOI: 10.1183/09031936.00053512].
19. Puthucheary Z, Skipworth JR, Rawal J, et al. The ACE gene and human performance: 12 years on. Sports Med 2011; 41: 433-448.
20. Wang P, Fedoruk MN, Rupert JL. Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents? Sports Med 2008; 38: 1065-1079.
21. Shrikrishna D, Astin R, Kemp PR, et al. Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease. Clin Sci (Lond) 2012; 123: 487-498.
22. American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 2009; 41: 687-708.
23. O'Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest 2004; 126: 903-914.
24. Dourado VZ, Tanni SE, Antunes LC, et al. Effect of three exercise programs on patients with chronic obstructive pulmonary disease. Braz J Med Biol Res 2009; 42: 263-271.
25. Ortega F, Toral J, Cejudo P, et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 669-674.
26. Vonbank K, Strasser B, Mondrzyk J, et al. Strength training increases maximum working capacity in patients with COPD randomized clinical trial comparing three training modalities. Respir Med 2012; 106: 557-563.
27. Menon MK, Houchen L, Singh SJ, et al. Inflammatory and satellite cells in the quadriceps of patients with COPD and the response to resistance training. Chest 2012; 142: 1134-1142.
28. Lewis MI, Fournier M, Storer TW, et al. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol 2007; 103: 1299-1310.
29. Houchen L, Steiner MC, Singh SJ. How sustainable is strength training in chronic obstructive pulmonary disease? Physiotherapy 2009; 95: 1-7.
30. Troosters T, Probst VS, Crul T, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 1072-1077.
31. Sillen MJ, Speksnijder CM, Eterman RM, et al. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature. Chest 2009; 136: 44-61.
32. Vivodtzev I, Debigare R, Gagnon P, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest 2012; 141: 716-725.
33. Giavedoni S, Deans A, McCaughey P, et al. Neuromuscular electrical stimulation prevents muscle function deterioration in exacerbated COPD: a pilot study. Respir Med 2012; 106: 1429-1434.
34. Abdellaoui A, Prefaut C, Gouzi F, et al. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J 2011; 38: 781-788.
35. Gloeckl R, Heinzelmann I, Baeuerle S, et al. Effects of whole body vibration in patients with chronic obstructive pulmonary disease a randomized controlled trial. Respir Med 2012; 106: 75-83.
36. Steiner MC, Roubenoff R, Tal-Singer R, et al. Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. Thorax 2012; 67: 1102-1109.
37. Evans WJ. Protein nutrition, exercise and aging. J Am Coll Nutr 2004; 23: Suppl., 601S-609S.
38. Weekes CE, Emery PW, Elia M. Dietary counselling and food fortification in stable COPD: a randomised trial. Thorax 2009; 64: 326-331.
39. van Vliets M, Spruit MA, Verleden G, et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 1105-1111.
40. Bhasin S, Storer TW, Berman N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 407-413.
41. Creutzberg EC, Wouters EF, Mostert R, et al. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003; 124: 1733-1742.
42. Casaburi R, Bhasin S, Cosentino L, et al. Anabolic effects of testosterone replacement and strength training in men with COPD. Am J Respir Crit Care Med 2004; 170: 870-878.
43. Baumann GP. Growth hormone doping in sports: a critical review of use and detection strategies. Endocr Rev 2012; 33: 155-186.
44. Burdet L, de Muralt B, Schutz Y, et al. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 1997; 156: 1800-1806.
45. Miki K, Maekura R, Nagaya N, et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One 2012; 7: e35708.
46. Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004; 169: 1022-1027.
47. Laviolette L, Lands LC, Dauletbaev N, et al. Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study. J Med Food 2010; 13: 589-598.
48. Al-Ghimlas F, Todd DC. Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis. Respirology 2010; 15: 785-795.
49. Deacon SJ, Vincent EE, Greenhaff PL, et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 233-239.
50. Remels AH, Schrauwen P, Broekhuizen R, et al. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 2007; 30: 245-252.
51. Rodacki CL, Rodacki AL, Pereira G, et al. Fish-oil supplementation enhances the effects of strength training in elderly women. Am J Clin Nutr 2012; 95: 428-436.
52. Castillero E, Nieto-Bona MP, Fernandez-Galaz C, et al. Fenofibrate, a PPARa agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. Am J Physiol Endocrinol Metab 2011; 300: E790-E799.
53. Sanchis-Gomar F, Lippi G. Telmisartan as metabolic modulator: a new perspective in sports doping? J Strength Cond Res 2012; 26: 608-610.
54. Goodyear LJ. The exercise pill too good to be true? N Engl J Med 2008; 359: 1842-1844.
55. Janssens W, Lehouck A, Carremans C, et al. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009; 179: 630-636.
56. Janssens W, Mathieu C, Boonen S, et al. Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. Vitam Horm 2011; 86: 379-399.
57. Jackson AS, Shrikrishna D, Kelly JL, et al. Vitamin D and skeletal muscle strength and endurance in COPD. Eur Respir J 2013; 41: 309-316.
58. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012; 156: 105-114.
59. Hornikx M, Van Remoortel H, Lehouck A, et al. Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of randomized data. Respir Res 2012; 13: 84.
60. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65: 215-220.
61. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D (2011 revision). Institute of Medicine. Washington, National Academies Press, 2011.
62. Caron AZ, Haroun S, Leblanc E, et al. The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice. BMC Musculoskelet Disord 2011; 12: 185.
63. Wagner KR, Fleckenstein JL, Amato AA, et al. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 2008; 63: 561-571.